Lipid A diversity and the innate host response to bacterial infection

Current Opinion in Microbiology

Volumn 1, Issue 1, 1998, Pages 36-42

  Darveau, Richard P ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; NEGIBACTERIA;

LIPID A;

ANIMAL; BIOSYNTHESIS; CHEMISTRY; GENETICS; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; HUMAN; IMMUNOLOGY; MICROBIOLOGY; MOUSE; REVIEW;

ANIMALS; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; LIPID A; MICE;

EID: 0031988039     PISSN: 13695274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1369-5274(98)80140-9     Document Type: Article

References (63)

1. Loppnow H, Brade H, Dürrbaum I, Dinarello CA, Kusumoto S, Rietschel E Th, Flad H-D: IL-1 induction-capacity of defined lipopolysaccharide partial structures. J Immunol 1989, 142:3229-3238.
2. Takada H, Kotani S: Structure-function relations of lipid A. In Bacterial Endotoxic Lipopolysaccharides, vol. I. Molecular Biochemistry and Cellular Biology, Edited by Morrison DC, Ryan JL. Boca Raton: CRC Press, Inc; 1992:107-130.
3. Pugin J, Schurer-Maly CC, Leturcq D, Moriarty A, Ulevitch RJ, Tobias PS: Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc Natl Acad Sci USA 1993, 90:2744-2748.
4. Springer TA: Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994, 76:301-314.
5. Morrison DC, Ryan JL: Endotoxins and disease mechanisms. Annu Rev Med 1987, 38:417-432.
6. Golenbock DT, Hampton RY, Qureshi N, Takayama K, Raetz CRH: Lipid A-like molecules that antagonize the effects of endotoxins on human monocytes. J Biol Chem 1991, 266:19490-19498.
7. Kirikae T, Schade FU, Zähringer U, Kirikae F, Brade H, Kusumoto S, Kusama T, Rielschel E Th: The significance of the hydrophilic backbone and the hydrophobic fatty acid regions of lipid A for macrophage binding and cytokine induction. FEMS Immunol Med Microbiol 1994, 8:13-26.
8. Pohlman TH, Munford RS, Harlan JM: Deacylated lipopolysaccharide inhibits neutrophil adherence to endothelium induced by lipopolysaccharide in vitro. J Exp Med 1987, 165:1393-1402.
9. Tanamoto K-I: Predominant role of the substituents on the hydroxyl groups of 3-hydroxy fatty acids of non-reducing glucosamine in lipid A for the endotoxic and antagonistic activity. FEBS Lett 1994, 351:325-329.
10. Raetz CRH: Bacterial lipopolysaccharides: a remarkable family of bioactive macroamphiphiles. In Escherichia coli and Salmonella: Cellular and Molecular Biology, vol 1, edn 2. Edited by Neidhardt FCEA. Washington DC: American Society for Microbiology; 1996:1035-1063.
11. Munford RS, Hall CL: Detoxification of bacterial lipopolysaccharides (endotoxins) by a human neutrophil enzyme. Science 1986, 234:203-205.
12. Lynn WA, Golenbock DT: Lipopolysaccharide antagonists. Immunol Today 1992, 13:271-276.
13. Ogawa T: Chemical structure of lipid A from Porphyromonas (Bacteroides) gingivalis lipopolysaccharide. FEBS 1993, 332:197-201.
14. Kumada H, Haishima Y, Umemoto T, Tanamoto K-I: Structural study on the free lipid A isolated from lipopolysaccharide of Porphyromonas gingivalis. J Bacteriol 1995, 177:2098-2106.
15. Qureshi N, Kaltashov I, Walker K, Doroshenko V, Cotter RJ, Takayama K, Sievert TR, Rice PA, Lin J-S, Golenbock DT: Structure of the monophosphoryl lipid A moiety obtained from the lipopolysaccharide of Chlamydia trachomatis. J Biol Chem 1997, 272:10594-10600.
16. Mattsby-Baltzer I, Mielniczuk Z, Larsson L, Lindgren K, Goodwin S: Lipid A in Helicobacter pylori. Infect Immun 1992, 60:4383-4387.
17. Wilkinson SG: Composition and structure of lipopolysaccharides from Pseudomonas aeruginosa. Rev Infect Dis 1983, 5:S941-S949.
18. Fujiwara T, Ogawa T, Sobue S, Hamada S: Chemical, immunobiological and antigenic characterizations of lipopolysaccharides from Bacteroides gingivalis strains. J Gen Microbiol 1990, 136:319-326.
19. Muotiala A, Helander IM, Pyhala L, Kosunen TU, Moran AP: Low biological activity of Helicobacter pylori lipopolysaccharide. Infect Immun 1992, 60:1714-1716.
20. Ingalls RR, Rice PA, Qureshi N, Takayama K, Lin JS, Golenbock DT: The inflammatory cytokine response to Chlamydia trachomatis infection is endotoxin mediated. Infect Immun 1995, 63:3125-3130.
21. Darveau RP, Cunningham MD, Bailey T, Seachord C, Ratcliffe K, Bainbridge B, Dietsch M, Page RC, Aruffo A: Ability of bacteria associated with chronic inflammatory disease to stimulate e-selectin expression and promote neutrophil adhesion. Infect Immun 1995, 63:1311-1317.
22. Takayama K, Qureshi N, Beutler B, Kirkland TN: Diphosphoryl lipid A from Rhodopseudomonas sphaeroides ATCC 17023 blocks induction of cachectin in macrophages by lipopolysaccharide. Infect Immun 1989, 57:1336-1338.
23. Magnuson DK, Weintraub A, Pohlman TH, Maier RV: Human endothelial cell adhesiveness for neutrophils, induced by Escherichia coli lipopolysaccharide in vitro, is inhibited by Bacteroides fragilis lipopolysaccharide. J Immunol 1989, 143:3025-3030.
24. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC: CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990, 249:1431-1433.
25. Pugin J, Schurer-Maly CC, Leturcq D, Moriarty A, Ulevitch RJ, Tobias PS: Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc Natl Acad Sci USA 1993, 90:2744-2748.
26. Cunningham MD, Seachord C, Ratcliffe K, Bainbridge B, Aruffo A, Darveau RP: Helicobacter pylori and Porphyromonas gingivalis lipopolysaccharides are poorly transferred to recombinant soluble CD14. Infect Immun 1996, 64:3601-3608.
27. Beamer LJ, Carroll SF, Eisenberg D: Crystal structure of human BPI and two bound phospholipids at 2.4 angstrom resolution. Science 1997, 276:1861-1864. This article describes the structural characteristics of human bactericidal/permeability increasing protein (BPI) at a crystal structure resolution of 2.4A. BPI is closely related to lipopolysaccharide-binding protein (LBP) and alignment of the amino acid sequences shows that structurally important residues are conserved. BPI was shown to interact with the acyl chains of phosphatidylcholine and it was postulated that both BPI and LBP interact with the acyl chains of lipopolysaccharide. This provides the first evidence of those structural components of lipid A that are recognized by LBP.
28. Shapiro RA, Cunningham MD, Ratcliffe K, Seachord C, Blake J, Bajorath J, Aruffo A, Darveau RP: Identification of CD14 residues involved in specific lipopolysaccharide recognition. Infect Immun 1997, 65:293-297. This article was the first to identify single point mutations in CD14 that have significant effects on its ability to bind to lipopolysaccharide (LPS). Specific charge reversal mutations had the greatest effect on LPS binding, pointing out the importance of charge in CD14 recognition of LPS. In addition, it was shown that CD14 can selectively recognize two different LPS species. Although this has therapeutic potential, additional data (RP Darveau, J Bajorath, C Seachord, MC Cunningham, unpublished data) suggest that CD14 presents a charged surface for LPS binding and the importance of specific charge interactions remains unknown.
29. Viriyakosol S, Kirkland TN: A region of human CD14 required for lipopolysaccharide binding. J Biol Chem 1995, 270:361-368.
30. Wright SD: CD14 and innate recognition of bacteria. J Immunol 1995, 155:6-8.
31. Kitchens RL, Munford RS: Enzymatically deacylated lipopolysaccharide (LPS) can antagonize LPS at multiple sites in the LPS recognition pathway. J Biol Chem 1995, 270:9904-9910.
32. Kitchens RL, Ulevitch RJ, Munford RS: Lipopolysaccharide (LPS) partial structures inhibit responses to LPS in a human macrophage cell line without inhibiting LPS uptake by a CD14-mediated pathway. J Exp Med 1992, 176:485-494.
33. Delude RL, Savedra R Jr, Zhao H, Thieringer R, Yamamoto S, Fenton MJ, Golenbock DT: CD14 enhances cellular responses to endotoxin without imparting ligand-specific recognition. Proc Natl Acad Sci USA 1995, 92:9288-9292.
34. Shaw El, Wood DO: Characterization of a Rickettsia rickettsii DNA fragment analogous to the fir A-ORF17-lpxA region of Escherichia coli. Gene 1994, 14:109-113.
35. Vuorio R, Härkönen T, Tolvanen M, Vaara M: The novel hexapeptide motif found in the acyltransferases LpxA and LpxD of lipid A biosynthesis is conserved in various bacteria. FEBS Letters 1994, 337:289-292.
36. Servos S, Khan S, Maskell D: Cloning and expression of genes encoding lipid biosynthesis from Haemophilus influenzae type b. Gene 1996, 175:137-141.
37. Hyland SA, Eveland SS, Anderson MS: Cloning, expression, and purification of UDP-3-O-Acyl-GlcNAc deacetylase from Pseudomonas aeruginosa: a metalloamidase of the lipid A biosynthesis pathway. J Bacteriol 1997, 179:2029-2037.
38. Odegaard TJ, Kaltashov IA, Cotter RJ, Steeghs L, van der Ley P, Khan S, Maskell DJ, Raetz CR: Shortened hydroxyacyl chains on lipid A of Escherichia coli cells expressing a foreign UDP-N-acetylglucosamine O-acyltransferase. J Biol Chem 1997, 272:19688-19696. These authors constructed the first genetically engineered strain with an altered lipid A fatty acid composition. The authors were able to complement an lpxA mutation in E. coli with the lpxA gene from Neisseria meningitidis. The resultant E. coli strain was viable yet the lipid A contained the shorter fatty acids characteristic of N. meningitidis. This approach to the study of lipid A function in bacteria will be invaluable in the study of lipid A function in host interactions.
39. Rick PD, Osborn MJ: Isolation of a mutant of Salmonella typhimurium dependent on D-Arabinose-5-phosphate for growth and synthesis of 3-deoxy-D-mannoctulosonate (ketodeoxyoctonate). Proc Nat Acad Sci USA 1972, 69:3756-3760.
40. Galloway SM, Raetz CRH: A mutant of Escherichia coli defective in the first step of endotoxin biosynthesis. J Biol Chem 1990, 169:6394-6402.
41. Beall B, Lutkenhaus J: Sequence analysis, transcriptional organization, and insertional mutagenesis of the envA gene of Escherichia coli. J Bacteriol 1987, 169:5408-5415.
42. Lathe R, Lecocq J-P: The firA gene, a locus involved in the expression of rifampicin resistance in Escherichia coli. Mol Gen Genet 1977, 154:43-51.
43. Nishijima M, Raetz CRH: Membrane lipid biogenesis in Escherichia coli: identification of genetic loci for phosphatidylglycerophosphate synthetase and construction of mutants lacking phosphatidylglycerol. J Biol Chem 1979, 254:7837-7844.
44. Clementz T, Raetz CRH: A gene coding for 3-deoxy-D-manno-octulosonic-acid transferase in Escherichia coli. J Biol Chem 1991, 266:9687-9696.
45. Karow M, Fayet O, Cegielska A, Ziegelhoffer T, Georgopoulos C: Isolation and characterization of the Escherichia coli htrB gene, whose product is essential for bacterial viability above 33°C in rich media. J Bacteriol 1991, 173:741-750.
46. Garrett TA, Kadrmas JL, Raetz CRH: Identification of the gene encoding the Escherichia coli lipid A 4 kinase: facile phosphorylation of endotoxin analogs with recombinant LpxK. J Biol Chem 1997, 272:21855-21864.
47. A. Identifying msbB as a gene encoding a structural, not a regulatory, protein for secondary fatty acid transfer to lipid A provided the definition needed to study this gene product in other systems.
48. Clementz T, Bednarski JJ, Raetz CRH: Function of the htrB high temperature requirement gene of Escherichia coli in the acylation of lipid A: HtrB catalyzed incorporation of laurate. J Biol Chem 1996, 271:12095-12102.
49. Somerville JE Jr, Cassiano L, Bainbridge B, Cunningham MD, Darveau R: A novel Escherichia coli lipid A mutant that produces an antiinflammatory lipopolysaccharide. J Clin Invest 1996, 997:359-365. These authors employed a unique screen to identify mutations in Escherichia coli lipid A biosynthesis. Mutants with decreased ability to stimulate E-selectin expression from endothelial cells were identified. A mutation in the msbB gene resulted in the production of lipopolysaccharide that only lacked myristate, identifying the importance of this secondary fatty acid for host cell recognition. This was the first report of a lipid A mutation that was not conditionally lethal for growth and was used to confirm the significant role of lipid A when viable bacteria are presented to host defense cells.
50. Karow M, Georgopoulos C: Isolation and characterization of the Escherichia coli msbB gene, a multicopy suppressor of null mutations in the high-temperature requirement gene htrB. J Bacteriol 1992, 174:702-710.
51. Sorensen PG, Lutkenhaus J, Young K, Eveland SS, Anderson MS, Raetz CRH: Regulation of UDP-3-O-[R-3-hydroxymyristoyl] -N-acetylglucosamir.e deacetylase in Escherichia coli: the second enzymatic step of lipid A biosynthesis. J Biol Chem 1996, 271:25898-25905. This article describes an increase in the specific activity of LpxC when the activity of LpxA is inhibited. An increase in the specific activity of LpxC, the first committed step in lipid A synthesis, indicates that E coli may be able to regulate the amount of lipid A synthesized in response to the lipid A content of its outer membrane. Several different innate host defense components act by disrupting the lipopolysaccharide barrier of the outer membrane and this article provides a means for testing the hypothesis that E. coli may respond to host attack by increasing lipid A synthesis.
52. Onishi HR, Pelak BA, Gerckens LS, Silver LL, Kahan FM, Chen M-H, Patchett AA, Galloway SM, Hyland SA, Anderson MS, Raetz CHR: Antibacterial agents that inhibit lipid A biosynthesis. Science 1996, 274:980-982.
53. Tesh VL, Duncan RL, Morrison DC: The interaction of Escherichia coli with normal human serum: the kinetics of serum-mediated lipopolysaccharide release and its dissociation from bacterial killing. J Immunol 1986, 137:1329-1335.
54. Ellison RT III, Giehl TJ, LaForce FM: Damage of the outer membrane of enteric gram-negative bacteria by lactoferrin and transferrin. Infect Immun 1988, 56:2774-2781.
55. Wiese A, Brandenburg K, Carroll SF, Rietschel ET, Seydel U: Mechanisms of action of bactericidal/permeability-increasing protein BPI on reconstituted outer membranes of gram-negative bacteria. Biochemistry 1997, 36:10311-10319.
56. Young GM, Miller VL: Identification of novel chromosomal loci affecting Yersinia enterocolitica pathogenesis. Mol Microbiol 1997, 25:319-328. This article identified Yersinia enterocolitica bacterial chromosomal genes that were preferentially expressed after intragastric ingestion in mice. One gene was found to encode a protein with homology to LpxA from Y. enterocolitica, yet was distinct from other characterized acyltransferases. These data remain speculative but suggest that Y. enterocolitica may contain an lpxA analogue which is activated in the in vivo environment and alters the lipid A fatty acid composition.
57. Miller SI, Kukral AM, Mekalanos JJ: A two-component regulatory system (phoP phoQ) controls Salmonella typhimurium virulence. Proc Natl Acad Sci USA 1989, 86:5054-5058.
58. Miller SI, Mekalanos JJ: Constitutive expression of the phoP regulon attenuates Salmonella virulence and survival within macrophages. J Bacteriol 1990, 172:2485-2490.
59. Guo L, Lim KB, Gunn JS, Bainbridge B, Darveau RP, Hackett M, Miller SI: Regulation of lipid A modifications by Salmonella typhimurium virulence genes phoP-phoQ. Science 1997, 276:250-253. This article examined the lipid A composition of Salmonella typhimurium strains with mutations in the virulence genes phoP-phoQ. It was found that mutations in the phoP-phoQ system, which regulates numerous genes in response to host microenvironments, induced structural modifications of lipid A. These modifications altered lipopolysaccharide-mediated expression of E-selectin by endothelial cells and tumor necrosis factor-α expression by adherent monocytes. These data provide the strongest evidence to date that lipid A may be altered in response to host microenvironments.
60. Makela PH, Msarvas M, Calcagno S, Lounatmaa K: Isolation and characterization of polymyxin-resistant mutants of Salmonella. FEMS Microbiol Lett 1978, 3:323-326.
61. Roland KL, Martin LE, Esther CR, Spitznagel JK: Spontaneous pmrA mutants of Salmonella typhimurium LT2 define a new two-component regulatory system with a possible role in virulence. J Bacteriol 1993, 175:4154-4164.
62. Gunn JS, Miller SI: PhoP-PhoQ activates transcription of pmrAB, encoding a two-component regulatory system involved in Salmonella typhimurium antimicrobial peptide resistance. J Bacteriol 1996, 178:6857-6864.
63. 2+ as an extracellular signal: environmental regulation of Salmonella virulence. Cell 1996, 84:165-174.